Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Allogeneic and Autologous Stem Cell Transplant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT00180115
What this trial is testing

AML96 - Risk-Adapted and Randomized Postremission-Therapy for Adult Acute Myeloid Leukemia Patients

Who this might be right for
Leukemia, Nonlymphoblastic, Acute
Technische Universität Dresden 400
Testing effectiveness (Phase 2)Study completedNCT00005613
What this trial is testing

Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Disease

Who this might be right for
Lymphoma
H. Lee Moffitt Cancer Center and Research Institute 147
Testing effectiveness (Phase 2)UnknownNCT00702247
What this trial is testing

Tandem Autologous- Nonmyeloablative Allogeneic Transplant for Newly Diagnosed Multiple Myeloma (Trapianto Tandem Autologo-Allogenico Non Mieloablativo Nel Mieloma Alla Diagnosi)

Who this might be right for
Multiple Myeloma
Azienda Ospedaliera San Giovanni Battista
Early research (Phase 1)UnknownNCT04174898
What this trial is testing

MSC Infusion for Anti-aging and Regenerative Therapy

Who this might be right for
Aging WellRegenerative Medicine
Landmark Medical Centre Sdn Bhd 100
Testing effectiveness (Phase 2)Study completedNCT01264315
What this trial is testing

Safety And Efficacy Of Lenalidomide As Maintenance Therapy In Patients With Newly Diagnosed Multiple Myeloma Following A Tandem Autologous-Allogeneic Transplant

Who this might be right for
Multiple Myeloma
Fondazione EMN Italy Onlus 53
Not applicableStudy completedNCT04194840
What this trial is testing

Transplant Wellness Clinic for Elderly or High Risk Patients Undergoing BMT

Who this might be right for
Stem Cell Transplant ComplicationsMyelomaLymphoma+1 more
Case Comprehensive Cancer Center 20
Large-scale testing (Phase 3)UnknownNCT02059720
What this trial is testing

Haplo-SCT vs ASCT With or Without Decitabine in AML CR1

Who this might be right for
Acute Myeloid Leukemia
The First Affiliated Hospital of Soochow University 212
Testing effectiveness (Phase 2)Study completedNCT01426295
What this trial is testing

Pharmaco-economic Study of a New Medical Device Performed From the Perspective of the Hospital

Who this might be right for
Hematologic Disease
Nantes University Hospital 92
Not applicableUnknownNCT04876326
What this trial is testing

Potential Use of Autologous and Allogeneic Mesenchymal Stem Cells in Patients With Multiple System Atrophy

Who this might be right for
Multiple System AtrophyParkinsonismMultiple System Atrophy, Parkinson Variant
Universitas Indonesia 15
Testing effectiveness (Phase 2)Active Not RecruitingNCT05261750
What this trial is testing

Autologous Dendritic Cells and Allogenic Dendritic Secretomes for Patients With Advanced Nasopharyngeal Cancer

Who this might be right for
Nasopharyngeal Cancer
PT. Prodia Stem Cell Indonesia 15
Early research (Phase 1)WithdrawnNCT02211027
What this trial is testing

Biological Vaccine: Semi-allogeneic Human Fibroblasts (MRC-5) Transfected With DNA

Who this might be right for
Head and Neck Squamous Cell Carcinoma (HNSCC)
Robert Ferris
Not applicableUnknownNCT01491230
What this trial is testing

Neutrophil Extracellular Traps Formation Post-hematopoietic Stem Cell Transplantation

Who this might be right for
Childhood Cancer
Tel-Aviv Sourasky Medical Center 50
Large-scale testing (Phase 3)Study completedNCT00075829
What this trial is testing

Stem Cell Transplantation in Individuals With Multiple Myeloma (BMT CTN 0102)

Who this might be right for
Multiple Myeloma
National Heart, Lung, and Blood Institute (NHLBI) 710
Early research (Phase 1)Ended earlyNCT00670410
What this trial is testing

Autologous Transplant Followed by Allogeneic Transplant for High Risk Neuroblastoma

Who this might be right for
Neuroblastoma
Columbia University 15
Testing effectiveness (Phase 2)Ended earlyNCT00482053
What this trial is testing

Phase 2 Poor Risk DLBCL of TLI and ATG Followed by Matched Allogeneic HT as Consolidation to Autologous HCT

Who this might be right for
Lymphoma, B-cellLymphoma, Non-HodgkinDiffuse Large B-cell Lymphoma (DLBCL)+1 more
Stanford University 3
Not applicableStudy completedNCT03467087
What this trial is testing

Safety and Feasibility of Electrical Muscle Stimulation During Stem Cell Transplantation or Intensive Chemotherapy

Who this might be right for
Electric Stimulation Therapy
University Hospital, Saarland 45
Early research (Phase 1)Study completedNCT03340766
What this trial is testing

Study Investigating the Safety and Efficacy of Blinatumomab in Combination With Pembrolizumab in Adults With Relapsed or Refractory Diffuse Large B Cell Lymphoma (DLBCL)

Who this might be right for
Relapsed or Refractory Diffuse Large B Cell Lymphoma (DLBCL)
Amgen 31
Post-approval studies (Phase 4)Not Yet RecruitingNCT07020559
What this trial is testing

Allogeneic vs Autologous PRP for Diabetic Wounds in Renal Dysfunction: a Randomized Controlled Trial

Who this might be right for
Diabetic WoundsPlatelet Rich PlasmaAllogeneic Blood Transfusions+1 more
Peking University Third Hospital 56
Not applicableNot Yet RecruitingNCT07577531
What this trial is testing

Autologous Versus Allogeneic Hematopoietic Stem Cell Transplantation for T-Lymphoblastic Leukemia/Lymphoma in First Complete Remission

Who this might be right for
T Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 84
Testing effectiveness (Phase 2)Study completedNCT02210065
What this trial is testing

Autologous Cytomegalovirus (CMV)-Specific Cytotoxic T Cells for Cytomegalovirus (CMV) Reactivation

Who this might be right for
LeukemiaLymphoma
M.D. Anderson Cancer Center 6
Next Page